Table 1.
Brain samples demographics. For age at death and post-mortem delay data are presented as mean and (standard deviation)
| Brain region | Female (%) | Age at death (years) | Post-mortem delay, (hours) | Braak stages 0/I-II/III-IV/V-VI | Thal phases 0/1–2/3/4–5 | CAA 0/1/2/3 | ||
|---|---|---|---|---|---|---|---|---|
| Cohort 1 | Control (n = 10) | FGM | 6 (60%) | 78.7 (17.7) | 77.6 (42.8) | 3/7/0/0 | 4/4/1/1 | 8/2/0/0 |
| AD (n = 10) | FGM | 4 (40%) | 69.4 (8.1) | 53.8 (28.9) | 0/0/0/10 | 0/0/0/10 | 1/1/1/7 | |
| PSP (n = 11) | FGM | 5 (45%) | 79.3 (9.0) | 47.9 (21.6) | na | na | na | |
| CBD (n = 10) | FGM | 3 (30%) | 68.6 (4.9) | 73.0 (25.1) | na | na | na | |
| PiD (n = 10) | FGM | 1 (10%) | 69.8 (4.8) | 67.4 (27.3) | na | na | na | |
| Cohort 2 | Control (n = 10) | FGM | 2 (20%) | 78.0 (7.0) | 56.0 (30.6) | 2/4/4/0 | 2/3/4/1 | 6/1/1/2 |
| AD (n = 10) | FGM | 6 (60%) | 75.8 (6.7) | 58.6 (23.1) | 0/0/0/10 | 0/0/0/10 | 0/2/2/6 | |
| CBD (n = 10) | FGM | 6 (60%) | 71.0 (7.2) | 78.0 (28.9) | 3/4/2/0 | 4/2/0/5 | 6/2/1/0 |
FGM = frontal grey matter, CAA = cerebral amyloid angiopathy, AD = (sporadic) Alzheimer’s diseases, PSP = progressive sopranuclear palsy, CBD = corticobasal neurodegeneration, PiD = Pick’s disease, na = not analyzed